BiotechTube
Home/Modulate Bio/Andrew Thomson
AT

Andrew Thomson

CEO

Modulate Bio

Therapeutic Areas

NeurologyPsychiatry

Modulate Bio Pipeline

DrugIndicationPhase
GABA-A PAM for Essential TremorEssential TremorPreclinical
GABA-A PAM for EpilepsyEpilepsyPreclinical
GABA-A PAM for AnxietyAnxiety DisordersDiscovery

Leadership Team at Modulate Bio

DD
Dario Doller, PhD
CSO
KH
Kevin Hodgetts, PhD
SAB Chair
View full Modulate Bio profile